Cargando…
Testing fractional doses of COVID-19 vaccines
Due to the enormous economic, health, and social costs of the COVID-19 pandemic, there are high expected social returns to investing in parallel in multiple approaches to accelerating vaccination. We argue there are high expected social returns to investigating the scope for lowering the dosage of s...
Autores principales: | Więcek, Witold, Ahuja, Amrita, Chaudhuri, Esha, Kremer, Michael, Simoes Gomes, Alexandre, Snyder, Christopher M., Tabarrok, Alex, Tan, Brandon Joel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872706/ https://www.ncbi.nlm.nih.gov/pubmed/35131899 http://dx.doi.org/10.1073/pnas.2116932119 |
Ejemplares similares
-
Targeted randomization dose optimization trials enable fractional dosing of scarce drugs
por: Boonstra, Philip S., et al.
Publicado: (2023) -
Fractional-dose inactivated poliovirus vaccine, India
por: Haldar, Pradeep, et al.
Publicado: (2019) -
Vaccine vial stopper performance for fractional dose delivery of vaccines
por: Jarrahian, Courtney, et al.
Publicado: (2017) -
Immunogenicity of Fractional Dose Inactivated Poliovirus Vaccine in India
por: Ahmad, Mohammad, et al.
Publicado: (2021) -
Fractional-dose yellow fever vaccination: an expert review
por: Roukens, Anna H E, et al.
Publicado: (2019)